In a systematic review of 7 studies (506 patients) with meta-analysis, EBUS-TBNA supernatant allowed molecular profiling in 87-100% of NSCLC samples, with 83-100% concordance with tissue (Cohen's κ 0.947) and 1-7.5 days faster turnaround.
Meta-analysisn = 506 patients
Vaz Rodrigues et al. Supernatant from endobronchial ultrasound-guided transbronchial needle aspiration samples for molecular profiling in NSCLC: a systematic review and meta-analysis